 SYDNEY, Oct. 6, 2021 PRNewswire -- Kazia Therapeutics Limited NASDAQ: KZIA; ASX: KZA, an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be presenting at the LD Micro Main Event, to be held virtually and in person from 12-14 October 2021. Since 2008, the LD Micro Main Event has established itself as one of the leading conferences for small-cap companies across a wide range of sectors. 